September’s boardroom moves brought seasoned pharma executives, investors, and scientific leaders into new governance and advisory roles across the life sciences sector.
The UK Biobank has teamed up with industry partners to create "the world’s most detailed, large-scale picture of the human immune system."
The first data from GSK's international trial of B7-H3-targeted ADC ris-rez in small cell lung cancer back up earlier results from a Chinese study.
Pharmaceutical supply chains have more data at their fingertips than ever before. The challenge is turning that information into foresight.
A €120m Series D for Swiss biotech Nouscom will support trials of a Lynch syndrome vaccine, with Soufflé, Estuary, and Microbiotica also raising cash.
Editor's Picks
